Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease

August 31, 2023 updated by: Noel Bairey Merz, Cedars-Sinai Medical Center

DEVELOPMENT OF A NOVEL STRESS TESTING PROTOCOL TO DEFINE THE RELATIONSHIP BETWEEN CORONARY MICROVASCULAR DYSFUNCTION AND DIASTOLOGY IN WOMEN WITH ANGINA BUT NO EVIDENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE

Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain, primarily impacts women. There are an estimated 2-3 million women in the US with MCD and about 100,000 new cases annually. Recent data from our research group suggests that coronary microvascular disease impairs the way the heart relaxes. This pilot study will attempt to exacerbate this phenotype in an effort to better understand the pathophysiology of the disease. The investigators will recruit 30 volunteers total (10 healthy calibration subjects, 10 women with microvascular disease, and 10 age-match women for the group with microvascular disease). Subjects will undergo a series of "stress" maneuvers in conjunction with advanced cardiac magnetic resonance imaging.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Barbra Streisand Women's Heart Center
  • Phone Number: 310-423-9666

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Fully understanding and willing to undergo study procedures
  2. Male or Female greater than or equal to 18 years of age
  3. Understanding and willing to sign consent form.

Exclusion Criteria:

  1. History of cardiovascular, pulmonary, or neurological disease
  2. Hypertension (sitting blood pressure >140/90 mmHg, with measurements recorded on at least 2 occasions)
  3. Diabetes
  4. Unable to give informed consent;
  5. Contra-indication to CMRI testing, including claustrophobia and metallic implants
  6. Adherence or retention issues;
  7. Women who are pregnant.
  8. Allergy to animal dander.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Women w/microvascular disease
10 women with microvascular disease
Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand
Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.
Subjects will perform leg exercise to increase metabolic demand.
Experimental: Normal controls
10 age-matched women with no evidence of microvascular disease
Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand
Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.
Subjects will perform leg exercise to increase metabolic demand.
Experimental: calibration
10 healthy individuals who will help to synchronize our imaging and stress testing maneuvers.
Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand
Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.
Subjects will perform leg exercise to increase metabolic demand.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Diastolic function by MRI
Time Frame: 24 hours
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Nelson, PhD, Cedars-Sinai Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2030

Study Registration Dates

First Submitted

November 22, 2014

First Submitted That Met QC Criteria

November 25, 2014

First Posted (Estimated)

November 26, 2014

Study Record Updates

Last Update Posted (Actual)

September 1, 2023

Last Update Submitted That Met QC Criteria

August 31, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Microvascular Coronary Dysfunction

Clinical Trials on Handgrip

Subscribe